(NASDAQ: ACOG) Alpha Cognition's forecast annual revenue growth rate of 76% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 29.74%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.61%.
Alpha Cognition's revenue in 2026 is $15,260,706.On average, 8 Wall Street analysts forecast ACOG's revenue for 2026 to be $571,473,034, with the lowest ACOG revenue forecast at $512,215,455, and the highest ACOG revenue forecast at $621,975,910. On average, 8 Wall Street analysts forecast ACOG's revenue for 2027 to be $1,094,403,201, with the lowest ACOG revenue forecast at $768,323,183, and the highest ACOG revenue forecast at $1,298,418,268.
In 2028, ACOG is forecast to generate $1,856,171,245 in revenue, with the lowest revenue forecast at $1,315,209,004 and the highest revenue forecast at $2,622,926,422.